![Anthony S. Chilton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony S. Chilton
No más puestos en curso
Historial de carrera de Anthony S. Chilton
Antiguos cargos conocidos de Anthony S. Chilton.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
INOTIV, INC. | Director/Miembro de la Junta | 14/02/2011 | 02/03/2012 |
Corporate Officer/Principal | 01/12/2008 | 28/01/2010 | |
Presidente | 28/01/2010 | 05/07/2012 | |
CARDINAL HEALTH, INC. | Corporate Officer/Principal | 01/01/1998 | - |
Genmedica Therapeutics SL
![]() Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Corporate Officer/Principal | 22/03/2010 | - |
Formación de Anthony S. Chilton.
University of East Anglia | Undergraduate Degree |
University of Hertfordshire | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 3 |
Reino Unido | 3 |
España | 2 |
Operativa
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
President | 1 |
Sectorial
Consumer Services | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
INOTIV, INC. | Commercial Services |
CARDINAL HEALTH, INC. | Distribution Services |
Empresas privadas | 1 |
---|---|
Genmedica Therapeutics SL
![]() Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Health Technology |
- Bolsa de valores
- Insiders
- Anthony S. Chilton
- Experiencia